Telmisartan
- Generic Name
- Telmisartan
- Brand Names
- Actelsar Hct, Micardis, Micardis-hct, Pritor, Twynsta, Tolura, Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), Telmisartan Teva Pharma, Telmisartan Actavis
- Drug Type
- Small Molecule
- Chemical Formula
- C33H30N4O2
- CAS Number
- 144701-48-4
- Unique Ingredient Identifier
- U5SYW473RQ
- Background
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arter...
- Indication
Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
- Associated Conditions
- Cardiovascular Events, Diabetic Nephropathy, Heart Failure, Hypertension
- Associated Therapies
- -
Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
- Conditions
- Interventions
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 176
- Registration Number
- NCT04218552
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
- Conditions
- Interventions
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 131
- Registration Number
- NCT04158076
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2019-08-08
- Target Recruit Count
- 300
- Registration Number
- NCT03956823
- Locations
- 🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
- Conditions
- Interventions
- First Posted Date
- 2019-03-13
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT03872232
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 26
- Registration Number
- NCT03705533
- Locations
- 🇨🇦
Algorithme Pharma, An Altasciences Company, Mount-Royal, Quebec, Canada
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
- Conditions
- Interventions
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- IlDong Pharmaceutical Co Ltd
- Target Recruit Count
- 134
- Registration Number
- NCT03566316
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
- Conditions
- Interventions
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- Steno Diabetes Center Copenhagen
- Registration Number
- NCT03504566
- Locations
- 🇩🇰
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT03267329
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT02933658
Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease
- Conditions
- Interventions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 114
- Registration Number
- NCT02593110
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Tulane University, New Orleans, Louisiana, United States
🇺🇸Ochsner Medical Center, New Orleans, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.